Dennis Matheis insider trades: DarioHealth (DRIO) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Dennis reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 23, 2026 | DRIO | ↑ Buy | 14,430 | $6.93 | $100K | Direct | Jul 28, 2026 (5d) |
| May 20, 2026 | LUCD | ↑ Buy | 245,000 | $1.00 | $245K | Direct | May 21, 2026 (1d) |
| Aug 20, 2025 | LUCD | ↑ Buy | 100,000 | $1.02 | $102K | Direct | Aug 22, 2025 (2d) |
| May 22, 2025 | LUCD | ↑ Buy | 350,000 | $1.31 | $458K | Direct | May 22, 2025 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Dennis Matheis's insider trades
Dennis Matheis is a director at DarioHealth (DRIO). Since May 22, 2025, Dennis has reported 4 open-market purchases worth $905K and no sales on SEC Form 4. In the last 12 months: 2 buys ($345K).
Their filings also include grants and awards (9 filings), conversions (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DRIO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.